New Clinical Study Results: CeraLyte 90 with L-histadine
Shows
Significant Life-Saving Properties for Victims of Cholera
Abstract of Clinical Study: Antidiarrheal Effects of L-Histidine–
Supplemented Rice-Based Oral Rehydration Solution
in the Treatment of Male
Adults with Severe Cholera
in Bangladesh: A Double-Blind, Randomized Trial
Published in The Journal of Infectious Diseases, April 2005
Summary: In a double-blind trial of 126
adult male patients with cholera, L-histidine was
mixed with CeraLyte 90 ORS
and administered to 62 patients; 64 patients received CeraLyte
without L-histidine.
The trial found that administration of CeraLyte 90 with
L-histidine significantly reduced the
frequency of stool output by nearly
35%. Additionally, over a period
of 48 hours, the duration
of illness was reduced, and patients needed less
of the ORS as the recovery period progressed.
Finally, no adverse effects
were observed in these patients.
Conclusion: CeraLyte 90 with L-histidine
reduces the weight of stool and the frequency of
stool output in cholera. This
combination
could be a useful and safe
adjunct treatment to combat
the deadly effects of cholera.
To obtain copy of the complete study, please contact:
The Journal of Infectious
Diseases
c/o The University of Chicago Press
1427 East 60th Street
Chicago, IL 60637-2954
phone:[773] 753-8028; fax:[773] 753-3616